Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Februar 2024 07:01 ET | Quelle: PMI

Achondroplasia Treatment Market Projected to Reach USD 3.2 Billion by 2034, Unveils Dynamics, Segmentation, and Growth Opportunities – By PMI

Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Achondroplasia Treatment Market size was valued at about USD 120.4 million in 2024 and expected to grow at CAGR...
03. März 2022 07:30 ET | Quelle: Helsinn Healthcare S.A.

Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.

Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S. Helsinn gains an exclusive...
02. Dezember 2020 14:39 ET | Quelle: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger

WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating BridgeBio Pharma, Inc. (“BridgeBio”) (NASDAQ GS: BBIO) regarding possible breaches...
05. Oktober 2020 21:00 ET | Quelle: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Eidos Therapeutics, Inc. Buyout

WILMINGTON, Del., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Eidos Therapeutics, Inc. (“Eidos”) (NASDAQ GS: EIDX) regarding possible breaches of...